Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.53 USD | -3.27% | -2.74% | +11.35% |
Apr. 23 | Kiniksa Pharmaceuticals Q1 Loss Widens, Revenue Rises | MT |
Apr. 23 | Transcript : Kiniksa Pharmaceuticals, Ltd., Q1 2024 Earnings Call, Apr 23, 2024 |
Financials (USD)
Sales 2024 * | 389M | Sales 2025 * | 536M | Capitalization | 1.39B |
---|---|---|---|---|---|
Net income 2024 * | -7M | Net income 2025 * | 42M | EV / Sales 2024 * | 2.94 x |
Net cash position 2024 * | 242M | Net cash position 2025 * | 386M | EV / Sales 2025 * | 1.86 x |
P/E ratio 2024 * |
-183
x | P/E ratio 2025 * |
33.4
x | Employees | 297 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 54.42% |
Latest transcript on Kiniksa Pharmaceuticals, Ltd.
1 day | -3.27% | ||
1 week | -2.74% | ||
Current month | +4.33% | ||
1 month | +11.92% | ||
3 months | -3.70% | ||
6 months | +35.25% | ||
Current year | +11.35% |
Managers | Title | Age | Since |
---|---|---|---|
Eben Tessari
FOU | Founder | 42 | 15-06-30 |
Sanj Patel
CEO | Chief Executive Officer | 54 | 15-06-30 |
Mark Ragosa
DFI | Director of Finance/CFO | 50 | 18-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Felix Baker
BRD | Director/Board Member | 55 | 15-09-30 |
Barry Quart
BRD | Director/Board Member | 67 | 15-09-30 |
Thomas Malley
BRD | Director/Board Member | 55 | 16-11-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.08% | 2 M€ | -.--% | ||
0.05% | 0 M€ | 0.00% | - | |
0.04% | 0 M€ | 0.00% | - | |
0.03% | 7 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 19.53 | -3.27% | 333,361 |
24-05-09 | 20.19 | -0.35% | 344,706 |
24-05-08 | 20.26 | -0.34% | 272,503 |
24-05-07 | 20.33 | +1.70% | 332,862 |
24-05-06 | 19.99 | -0.45% | 296,252 |
Delayed Quote Nasdaq, May 10, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.35% | 1.39B | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- KNSA Stock